Delivery Order SPE2DB20D2014-SPE2DB25FC98N
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units, with a ceiling value of $2,509.92. This competitively awarded, non-set-aside contract employs firm fixed pricing and is scheduled for ultimate completion on September 10, 2025. The delivery will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,513.21 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets in quantities of 1,000 units. This contract represents a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, issued one day prior on August 28, 2025. The award was made on a competitive basis with no set-aside designation. Performance will be executed from AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Metformin ER 500mg tablets (90-count supply) valued at $1,425.60 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order was issued on September 2, 2025, with an ultimate completion date of the same day, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Metformin is a first-line diabetes...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Metformin HCL ER 500 mg tablets (1,000 count) with a ceiling value of $2,523.13. The award, made on September 9, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 10, 2025. This order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,825.69 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4,564,179,958 tablets of Metformin HCl ER 500 mg. This delivery order was issued under an existing indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA. The IDC serves as the primary contract vehicle for AmerisourceBergen to deliver...
- The Defense Logistics Agency awarded a $1,250.16 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Metformin HCL ER 500 mg tablets (180-count units). This competitively awarded, firm fixed-price contract is classified as a child award under a larger indefinite delivery contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of September 3, 2025. The contract represents a routine...
- The Defense Logistics Agency (DLA) awarded a $1,102.08 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL 500 mg tablets (1000-count units). This non-set-aside contract was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.63 to AmerisourceBergen Drug Corp for 1,000 tablets of Metformin HCL ER 500 mg, with an ultimate completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under a larger vehicle. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery...
- The Defense Logistics Agency awarded a $4,403.59 delivery order to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (180-count units) on September 11, 2025, with an ultimate completion date of September 12, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and identifies Conshohocken, Pennsylvania as the place of performance, aligning with AmerisourceBergen's corporate headquarters location. The delivery order represents a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,604.67 firm fixed-price delivery order is for 4,567,457,222 units of Metformin HCL ER 500 mg tablets. The contract has an ultimate completion date of March 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC98NDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,967.89 to AmerisourceBergen Drug Corp for the supply of Metformin HCL ER 500 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 15, 2025. The award was made on September 12, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a discrete purchase under a larger indefinite delivery contract vehicle. This delivery order is issued under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. The Metformin supply order aligns with the DLA's pharmaceutical procurement strategy, supporting healthcare delivery across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated capability to meet federal procurement requirements through competitive awards and maintains a significant role in the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/12/25 |